Cosette expands into new dosage forms with facility acquisition

The ex-G&W Laboratories facility has a track record of producing liquid dosage forms

The Lincolnton facility

Cosette Pharmaceuticals, a generic pharmaceutical company primarily focused on extended topical and suppository products, has purchased G&W Laboratories' finished dosage manufacturing plant located in Lincolnton, NC, US.

"The purchase of the Lincolnton plant expands Cosette's capabilities into new dosage forms while simultaneously allowing us to enter a new business vertical that complements our overall growth strategy," said Walt Kaczmarek, President and CEO of Cosette.

The Lincolnton facility has a track record of producing liquid pharmaceuticals along with other differentiated dosage forms, and operates as a contract manufacturer across multiple presentations for select business partners.

“We look forward to integrating their expertise and capabilities to the Cosette family and adding value to the Cosette growth pathway," Kaczmarek added.